MAKO Surgical Corp. Schedules Second Quarter 2009 Earnings Release and Conference...

MAKO Surgical Corp. Schedules Second Quarter 2009 Earnings Release and
Conference Call for Tuesday, August 4, 2009

FORT LAUDERDALE, Fla., July 7, 2009 (GLOBE NEWSWIRE) -- MAKO Surgical Corp.
(Nasdaq:MAKO) announced today that it plans to release second quarter 2009
financial results after market close on Tuesday, August 4, 2009. Maurice R.
Ferre, M.D., President and Chief Executive Officer and Fritz L. LaPorte, Senior
Vice President and Chief Financial Officer of MAKO, will host a conference call
to review the second quarter 2009 results starting at 4:30 pm EDT on the same
day. The call will be concurrently webcast.

To listen to the conference call please dial 800-289-0569 for domestic callers
and 913-312-1301 for international callers approximately ten minutes prior to
the start time. To access the live audio broadcast or the subsequent archived
recording, visit the Investor Relations section of MAKO's website at
www.makosurgical.com. Following the call, a webcast replay will be available on
MAKO's website, and an audio replay will also be available by calling
888-203-1112 (719-457-0820 for international callers) and entering the passcode
1217640. Both the audio and webcast replays will be available through August 18,
2009.

About MAKO Surgical Corp.

MAKO Surgical Corp. is a medical device company that markets both its RIO(r)
Robotic-Arm Interactive Orthopedic system (RIO(r)) and its proprietary
RESTORIS(r) implants for minimally invasive orthopedic knee procedures. The MAKO
RIO is a surgeon-interactive tactile surgical platform that incorporates a
robotic arm and patient-specific visualization technology and prepares the knee
joint for the insertion and alignment of MAKO's resurfacing RESTORIS implants
through a minimal incision. The FDA-cleared RIO system allows surgeons to
provide a precise, consistently reproducible tissue-sparing, bone resurfacing
procedure called MAKOplasty(r) to a large, yet underserved patient-specific
population suffering from early to mid-stage osteoarthritic knee disease. MAKO
has an intellectual property portfolio of more than 250 licensed or owned
patents and patent applications relating to the areas of robotics, haptics,
computer assisted surgery and implants. Additional information can be found at
www.makosurgical.com.

-0-
CONTACT: MAKO Surgical Corp.
Investors:
Susan M. Verde
954-927-2044 x349
sverde@makosurgical.com

Westwicke Partners
Mark Klausner
443-213-0500
mark.klausner@westwicke.com